Follow
Hongxia Lin
Hongxia Lin
Rutgers University, Cancer Institute of New Jersey
No verified email
Title
Cited by
Cited by
Year
Targeting tumor metabolism with 2‐deoxyglucose in patients with castrate‐resistant prostate cancer and advanced malignancies
M Stein, H Lin, C Jeyamohan, D Dvorzhinski, M Gounder, K Bray, S Eddy, ...
The Prostate 70 (13), 1388-1394, 2010
2702010
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
PM Tedeschi, EK Markert, M Gounder, H Lin, D Dvorzhinski, SC Dolfi, ...
Cell death & disease 4 (10), e877-e877, 2013
2522013
Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies
H Lin, H Li, HJ Cho, S Bian, HJ Roh, MK Lee, JS Kim, SJ Chung, CK Shim, ...
Journal of pharmaceutical sciences 96 (2), 341-350, 2007
1742007
Liposome formulation of paclitaxel with enhanced solubility and stability
T Yang, FD Cui, MK Choi, H Lin, SJ Chung, CK Shim, DD Kim
Drug delivery 14 (5), 301-308, 2007
1352007
Enhancing effect of surfactants on fexofenadine· HCl transport across the human nasal epithelial cell monolayer
H Lin, M Gebhardt, S Bian, KA Kwon, CK Shim, SJ Chung, DD Kim
International journal of pharmaceutics 330 (1-2), 23-31, 2007
1032007
Air-Liquid Interface Culture of Serially Passaged Human Nasal Epithelial Cell Monolayer for In Vitro Drug Transport Studies
MK Lee, JW Yoo, H Lin, YS Kim, DD Kim, YM Choi, SK Park, CH Lee, ...
Drug Delivery 12 (5), 305-311, 2005
742005
Neutrophils clear bacteria associated with parasitic nematodes augmenting the development of an effective Th2-type response
JT Pesce, Z Liu, H Hamed, F Alem, J Whitmire, H Lin, Q Liu, JF Urban, ...
The Journal of Immunology 180 (1), 464-474, 2008
562008
Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer
H Lin, JW Yoo, HJ Roh, MK Lee, SJ Chung, CK Shim, DD Kim
European journal of pharmaceutical sciences 26 (2), 203-210, 2005
542005
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM 1) signaling, in patients with advanced melanoma
JM Mehnert, AW Silk, JH Lee, L Dudek, BS Jeong, J Li, JM Schenkel, ...
Pigment cell & melanoma research 31 (4), 534-540, 2018
362018
Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer TherapeuticsZn Metallochaperones Reactivate Mut p53 in Pancreatic Cancer
X Yu, S Kogan, Y Chen, AT Tsang, T Withers, H Lin, J Gilleran, B Buckley, ...
Clinical cancer research 24 (18), 4505-4517, 2018
292018
Suppression of cytosolic NADPH pool by thionicotinamide increases oxidative stress and synergizes with chemotherapy
PM Tedeschi, HX Lin, M Gounder, JE Kerrigan, EE Abali, K Scotto, ...
Molecular pharmacology 88 (4), 720-727, 2015
252015
Quantification of folate metabolism using transient metabolic flux analysis
PM Tedeschi, N Johnson-Farley, H Lin, LM Shelton, T Ooga, G Mackay, ...
Cancer & metabolism 3 (1), 1-14, 2015
232015
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
JM Mehnert, AD Kaveney, J Malhotra, K Spencer, D Portal, S Goodin, ...
Cancer chemotherapy and pharmacology 84, 899-907, 2019
192019
Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air–liquid interface method for nasal drug …
HJ Cho, MK Choi, H Lin, JS Kim, SJ Chung, CK Shim, DD Kim
Journal of Pharmacy and Pharmacology 63 (3), 385-391, 2011
182011
Preliminary results of a phase I trial of ABT-888, a poly (ADP-ribose) polymerase (PARP) inhibitor, in combination with cyclophosphamide.
AR Tan, D Gibbon, MN Stein, RA Moss, V Karantza, H Lin, M Gounder, ...
Journal of Clinical Oncology 28 (15_suppl), 3000-3000, 2010
172010
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
MN Stein, S Goodin, M Gounder, D Gibbon, R Moss, D Portal, D Lindquist, ...
Investigational new drugs 38, 855-865, 2020
162020
Pharmacokinetics and pharmacodynamics of 3, 3′-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes
TY Wu, Y Huang, C Zhang, ZY Su, S Boyanapalli, TO Khor, H Wang, H Lin, ...
Journal of pharmacokinetics and pharmacodynamics 42, 401-408, 2015
152015
A validated HPLC assay for the determination of R-(−)-gossypol in human plasma and its application in clinical pharmacokinetic studies
H Lin, MK Gounder, JR Bertino, ANT Kong, RS DiPaola, MN Stein
Journal of pharmaceutical and biomedical analysis 66, 371-375, 2012
152012
A second target of benzamide riboside: Dihydrofolate reductase
B Roussel, N Johnson-Farley, JE Kerrigan, KW Scotto, D Banerjee, ...
Cancer biology & therapy 13 (13), 1290-1298, 2012
142012
Cefoxitin plasma and subcutaneous adipose tissue concentration in patients undergoing sleeve gastrectomy
L Brunetti, L Kagan, G Forrester, LM Aleksunes, H Lin, S Buyske, ...
Clinical therapeutics 38 (1), 204-210, 2016
102016
The system can't perform the operation now. Try again later.
Articles 1–20